FOLH1 and posterior cortical atrophy: We performed a subgroup analysis to investigate the factors to predict downgrading in patients with Gleason 4+4 PCa with no other EAU high risk features (PSA < 20 ng/ml and cT2 stage and without extracapsular extension (ECE) suspicion on either mpMRI or PSMA PET-CT).